Skip to main content
T

Trillium

Provides customizable diagnostic testing and R&D services for biopharmaceutical companies, focusing on rare diseases, nutrition, and microbiome health. Trillium’s physician-approved solutions enable precise disease understanding, support clinical trials, and deliver personalized health insights to improve patient outcomes.

Rockville, United StatesFounded 202464200+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Biopharmaceutical companies often face challenges in accurately diagnosing and understanding complex diseases, particularly rare conditions, nutritional deficiencies, and microbiome-related health issues. Traditional diagnostic approaches may lack the precision needed to support clinical trials and deliver personalized health insights.

Solution

Trillium provides customizable diagnostic testing and R&D services to biopharmaceutical companies, enabling a more precise understanding of disease mechanisms and progression. The company's physician-approved solutions support clinical trials by generating new data and enhancing diagnostic testing capabilities. Trillium also delivers personalized health insights through safe and accurate diagnostic testing services, meeting individuals where they are and providing actionable answers. By embracing technological innovation and state-of-the-art methods, Trillium redefines the way personalized solutions are developed and delivered, ultimately aiming to improve patient outcomes.

Target Audience

Trillium's primary customers are biopharmaceutical companies seeking diagnostic and R&D support, as well as individuals seeking personalized health testing services.

Features

  • Diagnostic partnerships with biopharmaceutical companies to drive innovation in complex disease understanding.
  • Personalized testing services that provide individuals with accurate and actionable health information.
  • Research and development support for clinical trials, generating new data to advance diagnostic testing.
  • Focus on rare diseases, nutritional health, and microbiome health.
  • Physician-approved solutions ensuring clinical relevance and reliability.
  • State-of-the-art methods for collecting, performing, developing, and delivering personalized solutions.
This profile is AI-generated and may contain inaccuracies.